1 Mg Tablet

The "1 mg tablet" market is currently undergoing a significant shift toward precision dosing and micro-dosage formulations. Key findings from my analysis include:

• Pharmaceutical Trends: The 1mg dosage remains a critical therapeutic anchor for medications like Finasteride, Folic Acid, and Risperidone. A major emerging trend for 2026 is the expansion of Oral GLP-1 agonists, which are moving from injectables to more accessible tablet forms. Additionally, the 2026 Patent Cliff will see major brands like Januvia and Xeljanz facing patent expirations, opening the market for generic 1mg tablets.
• Supplement Trends: In the supplement sector, Phytomelatonin is a rising "clean" alternative, where 1mg of plant-derived melatonin is proving as effective as 10mg of synthetic versions. There is also a strong consumer pull toward micro-dosed nootropics for precise cognitive support.
• Technology & Delivery: The market for Orally Disintegrating Tablets (ODT) and Fast Melt technologies is projected to grow to $6.80 Billion by 2026, driven by demand for easier administration in pediatric and geriatric care.

I have compiled a detailed market trends report and identified relevant products matching these criteria. Please see the report below for the full synthesis.